Updated Applications of Stem Cells in Hypoplastic Left Heart Syndrome

Area of Science:

• Cardiology
• Regenerative Medicine
• Developmental Biology

Background:

• Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect impacting 2-3 neonates per 10,000 live births.
• While genetic factors are implicated, HLHS pathophysiology remains incompletely understood.
• Current treatments involve palliative surgery, but long-term complications like arrhythmias and heart failure necessitate further research.

Purpose of the Study:

• To provide a comprehensive review of HLHS, focusing on pathophysiology and stem cell-based therapeutic strategies.
• To explore the role of adult stem cells and pluripotent stem cells (PSCs) in understanding HLHS.
• To discuss emerging stem cell-derived techniques for HLHS research and treatment.

Main Methods:

• Literature review of existing research on HLHS and stem cell applications.
• Analysis of pathophysiological mechanisms and signaling molecules involved in HLHS.
• Exploration of stem cell therapies, cardiac organoids, and bioengineered tissues.

Main Results:

• Stem cell research is advancing the understanding of cardiac development and repair.
• Adult stem cells and PSCs offer potential for elucidating HLHS mechanisms.
• Cardiac organoids and bioengineered tissues show promise for disease modeling and drug screening.

Conclusions:

• Further understanding of HLHS pathophysiology is crucial for developing novel treatments.
• Stem cell-based approaches, including organoids and tissue engineering, hold significant potential for HLHS therapy.
• Regenerative medicine offers a promising future for managing HLHS and improving patient outcomes.